Results 41 to 50 of about 13,855 (204)

Reversible biliary occlusion in a small animal model: first description of a new technique

open access: yesInnovative Surgical Sciences, 2018
Experimental models with reversible biliary occlusion resulted in a high mortality of the animals, up to 20–60% according to the literature. Our aim was to assess a safe and valid technique for reversible biliary occlusion with a low mortality.
Richter Beate   +5 more
doaj   +1 more source

Expression and Clinical Significance of Cytokeratin-19 and Thymidine Kinase-1 in Advanced Gastrointestinal Cancer

open access: yesChinese Medical Journal, 2016
Background: As the clinical value of cytokeratin-19 (CK19) and thymidine kinase-1 (TK1) in advanced gastrointestinal cancer remains controversial, we investigated their expression and clinical significance in this disease.
Ying-Ying Du   +2 more
doaj   +1 more source

Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid [PDF]

open access: yesDiagnostic Pathology, 2008
Papillary carcinoma of the thyroid (PTC) is the commonest thyroid cancer. In the recent decades an obvious increase in the incidence of PTC has occurred. The pathological diagnosis of PTC is usually an easy diagnosis in the majority of cases. However since the introduction of follicular variant of PTC and the wide threshold range in interpretation of ...
Alowami Salem   +2 more
openaire   +3 more sources

Prognostic significance of CD44 and CK19 expression in head and neck squamous cell carcinoma

open access: yesЮжно-Российский онкологический журнал
Purpose of the study. To analyze and synthesize current scientific evidence on the role of CD44 and CK19 expression in the pathogenesis of head and neck squamous cell carcinoma (HNSCC), their diagnostic and prognostic significance, as well as their ...
Han Yuyao   +8 more
doaj   +1 more source

Immunohistochemical Expression of Cytokeratin 19 in Patients with Papillary Thyroid Carcinoma and its Mimics in Erbil, Kurdistan Region, Iraq

open access: yesZanco Journal of Medical Sciences, 2023
Background and objective: Papillary thyroid carcinoma (PTC) is the most common primary thyroid cancer. PTC diagnosis is based on the presence of classic nuclear features in most cases.
Tavga Hushair Dizeyi
doaj   +1 more source

Angiogenesis and CK19 expression in papillary thyroid carcinoma

open access: yesTrakia Journal of Science, 2015
Purpose: Aim of the present study is to evaluate immunohistochemically the diagnostic value of CK19 in papillary thyroid carcinoma (PC) and to determine the microvascular density (MDV) in tumor tissue by CD34. Methods: We studied immunohistochemical expression of CK19 in both tumor tissue and adjacent non-tumor tissue of ten patients that had undergone
D. Malinova, M. Tzaneva
openaire   +1 more source

CK19 and GPC3 expression in different histological variation of HCC.

open access: yes, 2016
Thin trabecular HCC was usually accompanied by the pseudoglandular structure (blue arrow head). This histological variant mostly showed CK19−/GPC3− expression (A). Majority of SHCCs showed CK19+/GPC3+ expression. But nearly half of CK19+/GPC3+ cases with
Hui Xia (133168)   +10 more
core   +1 more source

Validation of droplet digital PCR for cytokeratin 19 mRNA detection in canine peripheral blood and mammary gland

open access: yesScientific Reports, 2022
In humans, peripheral blood cytokeratin 19 (CK19) mRNA-positive circulating tumor cells (CTCs) was utilized to identify early-stage breast cancer patients with micrometastatic disease who are at risk for disease progression and monitor treatment response
Potsawat Tanvetthayanont   +4 more
doaj   +1 more source

Serum CK19-2G2 levels in breast cancer patients.

open access: yes, 2013
(A) The Mean of serum CK19-2G2 levels in healthy, benign, BC group. Serum CK19-2G2 levels in breast cancer patients are higher than those in the healthy and benign controls respectively.(BC vs Benign ...
Yanan Kong (384071)   +14 more
core   +1 more source

Validation of a screening platform to identify CK19+ cell mitogens.

open access: yes, 2012
A) Number of CK19+ cells at the end of the culture normalized to the number obtained in basal serum-free medium culture. B) Fraction of CK19+ cells that incorporated BrdU during the last day of culture, normalized to BrdU incorporation in basal medium ...
James M. Piret (176798)   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy